Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data.
Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Tetracyclines and neuromuscular disorders.
Mesenchymal stem cell transplantation in multiple sclerosis.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.
Development of the Cell Population in the Brain White Matter of Young Children.
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Environmental factors in multiple sclerosis.
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.
Pages
« first
‹ previous
…
318
319
320
321
322
323
324
325
326
…
next ›
last »